FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s

10 months ago 109

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.